CMPX
Compass Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.38
+0.42%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-44.2%
Return on equity
-38.6%
Return on assets
-46.2%
Return on invested capital
0.00x
Asset turnover
-$54.8M
Cash from operations
$1.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026